GlobeNewswire 2016-11-08 Anke Linnartz joins MorphoSys as Head of Corporate Communications and Investor Relations

GlobeNewswire 2016-11-07 MorphoSys AG Reports Results for the First Nine Months of 2016

GlobeNewswire 2016-11-03 MorphoSys Announces Presentations of Clinical Data at Upcoming American Society of Hematology (ASH) ...

GlobeNewswire 2016-11-02 MorphoSys and LEO Pharma Enter into Strategic Alliance to Develop Therapeutic Antibodies in Dermatol...

GlobeNewswire 2016-10-28 MorphoSys to Host Q3 2016 Conference Call on November 7, 2016

GlobeNewswire 2016-10-20 MorphoSys Receives Clinical Milestone for Start of Phase 1 Trial with Novel Cancer Antibody

GlobeNewswire 2016-10-17 MorphoSys Presents Updated Clinical Results for MOR202 at Medical Conference

GlobeNewswire 2016-10-01 MorphoSys Announces That Its Licensee Janssen Reports Positive Results From A Phase 3 Study of Gusel...

GlobeNewswire 2016-10-01 Ad hoc: MorphoSys Announces That Its Licensee Janssen Reports Positive Results From A Phase 3 Study ...

GlobeNewswire 2016-09-29 MorphoSys and Galapagos Start First-In-Patient Dosing of IL-17C Antibody MOR106 in Atopic Dermatitis

GlobeNewswire 2016-09-19 Lanthio Pharma Expands Management Team

GlobeNewswire 2016-09-12 MorphoSys Appoints Four R&D Experts to its Newly Formed Scientific Advisory Board

GlobeNewswire 2016-09-06 MorphoSys Initiates Phase 2/3 Trial of CD19 Antibody MOR208 plus Bendamustine in Patients with Relap...

GlobeNewswire 2016-08-29 MorphoSys to Present at Upcoming Investor Conferences

GlobeNewswire 2016-08-03 MorphoSys Successfully Completes Safety Run-in of MOR208 in L-MIND Combination Study in Patients wit...

GlobeNewswire 2016-08-01 MorphoSys AG Reports Results for the First Six Months of 2016

GlobeNewswire 2016-07-25 MorphoSys to Host Q2 2016 Conference Call on August 1, 2016

GlobeNewswire 2016-07-04 MorphoSys Receives Clinical Milestone for Start of Phase 1 Trial in Prevention of Thrombosis with No...

GlobeNewswire 2016-06-17 MorphoSys Reports Publication of Clinical Case Report of a Blood Cancer (DLBCL) Patient Showing Long...

GlobeNewswire 2016-06-06 MorphoSys Presents Updated Clinical Data for MOR202 in Multiple Myeloma and for MOR208 in Non-Hodgki...

GlobeNewswire 2016-06-02 MorphoSys AG Reports Outcome of Annual General Meeting 2016

GlobeNewswire 2016-06-01 MorphoSys to Present at Six Upcoming Conferences